Singapore: A two month old baby from Germany is the first infant in Europe to receive Sanofi Pasteur-MSD's 6-in-1 paedia...
Singapore: Biological E has entered into a long term supply agreement with Vacsera (and its subsidiary Egyvac), an Egypt...
Singapore: The World Health Organization (WHO) has confirmed China's polio-free status following the country's successf...
Singapore: Novartis has confirmed its confidence in the safety and efficacy of its seasonal influenza vaccines Agrippal ...
Singapore: Though still some years away from clinical development in humans, a new study conducted at Braasch Biotech, a...
Singapore: In an ongoing case where Perth-based Ms Saba Button suffered severe disability following a flu vaccine manufa...
Singapore: Australian Therapeutic Goods Administration (TGA) has approved Novartis' Bexsero, a multi-component Meningoco...
Singapore: Australian biotech firm, Themis Bioscience GmbH declared the successful interim results of their prophylactic...
Singapore: Business intelligence provider GlobalData estimates that India is expected to exhibit a great surge in H1N1 ...
Singapore: The world's first vaccine against a strain of enterovirus has now been developed by Chinese researchers. The ...
Singapore: The World Health Organization (WHO) is on the verge of approving a Chinese-made vaccine for Japanese encephal...
Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, t...
Singapore: Altravax has been awarded two research grants worth a total of $3.45 million from the NIH's National Institut...
Singapore: Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a bioph...
Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agre...
Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has ...
Singapore: The results of the phase III clinical trials of a malaria vaccine being developed by British pharmaceutical m...
Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press confere...
